AdvisorShares Pure US Cannabis ETF

Cannabis ETF $MSOS, is well off its highs as the whole industry still awaits for the potential reclassification from the DEA on cannabis, which currently is still considered a Schedule 1 drug. And over the weekend The Wall Street Journal reported that some federal officials still have concerns about loosening restrictions on marijuana.

Share this article:

About the Author:

AdvisorShares Pure US Cannabis ETF

Joey Ramson

PRISM Market View Alerts

Get your dose of PRISM Market
View news, right in your inbox

Mailchimp Signup